We are live on
!
Find out more
Anika Therapeutics
ANIK
ANIK
120 hedge funds and large institutions have $376M invested in Anika Therapeutics in 2023 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 39 increasing their positions, 46 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
7,217% more call options, than puts
Call options by funds: $2.12M | Put options by funds: $29K
5% more capital invested
Capital invested by funds: $360M → $376M (+$16.4M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.38% less ownership
Funds ownership: 89.71% → 89.32% (-0.38%)
4% less funds holding
Funds holding: 125 → 120 (-5)
15% less repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 46
24% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 17
Holders
120
Holders Change
-5
Holders Change %
-4%
% of All Funds
1.91%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
39
Reduced
46
Closed
17
Calls
$2.12M
Puts
$29K
Net Calls
+$2.09M
Net Calls Change
-$133K
Top Buyers
| 1 |
CP
Caligan Partners
New York
|
+$3.68M |
| 2 |
BFM
Boothbay Fund Management
New York
|
+$3.56M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
+$2.04M |
| 4 |
Morgan Stanley
New York
|
+$2.03M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
+$1.53M |
